These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2689017

  • 1. Antipsoriatic effect of local corticosteroids--O2-consumption and blood flow measurements compared to clinical parameters.
    Broby-Johansen U, Kristensen JK.
    Clin Exp Dermatol; 1989 Mar; 14(2):137-40. PubMed ID: 2689017
    [Abstract] [Full Text] [Related]

  • 2. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U, Karlsmark T, Petersen LJ, Serup J.
    Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
    [Abstract] [Full Text] [Related]

  • 3. Antipsoriatic effect of semi-occlusive treatment--O2-consumption, blood flow and temperature measurements compared to clinical parameters.
    Broby-Johansen U, Kristensen JK.
    Clin Exp Dermatol; 1989 Jul; 14(4):286-8. PubMed ID: 2591090
    [Abstract] [Full Text] [Related]

  • 4. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM, van Erp PE, van De Kerkhof PC.
    Dermatology; 1999 Jul; 199(4):323-7. PubMed ID: 10640842
    [Abstract] [Full Text] [Related]

  • 5. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
    Kragballe K, Larsen FG.
    Acta Derm Venereol; 1991 Jul; 71(6):540-2. PubMed ID: 1685841
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing.
    Volden G.
    Acta Derm Venereol; 1992 Jul; 72(1):69-71. PubMed ID: 1350154
    [Abstract] [Full Text] [Related]

  • 7. Treatment of psoriasis with triamcinolone acetonide 0.1% under occlusion: a comparison of two hydrocolloid dressings.
    González JR, Cabán F.
    Bol Asoc Med P R; 1990 Jul; 82(7):288-91. PubMed ID: 2261015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Psoriasis treated with clobetasol propionate and photochemotherapy.
    Gould PW, Wilson L.
    Br J Dermatol; 1978 Feb; 98(2):133-6. PubMed ID: 343806
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic response to a dermatologic patch and betamethasone valerate 0.1 percent cream in the management of chronic plaques in psoriasis.
    Wilkinson RD, Ohayon M.
    Cutis; 1990 Jun; 45(6):468-70. PubMed ID: 2190758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The value of colloid dressings in psoriasis.
    Agius A, Borg E, Pace JL.
    Adv Exp Med Biol; 1999 Jun; 455():377-85. PubMed ID: 10599373
    [Abstract] [Full Text] [Related]

  • 15. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid occlusive dressing for one week.
    Juhlin L.
    Acta Derm Venereol; 1989 Jun; 69(4):355-7. PubMed ID: 2568063
    [Abstract] [Full Text] [Related]

  • 16. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ, Prins M, Tosserams EF, Gerritsen MJ, Van Der Valk PG, Van De Kerkhof PC.
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [Abstract] [Full Text] [Related]

  • 17. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M, Berger C, Filipp N, Hundertmark U, Loewel R.
    Z Hautkr; 1981 Aug 15; 56(16):1066-70. PubMed ID: 7027655
    [Abstract] [Full Text] [Related]

  • 18. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
    Gip L, Hamfelt A.
    Cutis; 1984 Feb 15; 33(2):215-7, 220-2, 224. PubMed ID: 6365474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.